{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T16:36:20Z","timestamp":1794846980639,"version":"4.9.1"},"reference-count":56,"publisher":"American Association for Cancer Research (AACR)","issue":"23","license":[{"start":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T00:00:00Z","timestamp":1669939200000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"crossref","award":["1062702"],"award-info":[{"award-number":["1062702"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"crossref","award":["1081178"],"award-info":[{"award-number":["1081178"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"crossref","award":["1104348"],"award-info":[{"award-number":["1104348"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"crossref","award":["1116955"],"award-info":[{"award-number":["1116955"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"crossref","award":["2008692"],"award-info":[{"award-number":["2008692"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"crossref","award":["1183070"],"award-info":[{"award-number":["1183070"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Stafford Fox Medical Research Foundation"},{"DOI":"10.13039\/501100023250","name":"The Lorenzo and Pamela Galli Medical Research Trust","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100023250","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000951","name":"Cancer Council Victoria","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000951","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000951","name":"Cancer Council Victoria","doi-asserted-by":"crossref","award":["1186314"],"award-info":[{"award-number":["1186314"]}],"id":[{"id":"10.13039\/501100000951","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008018","name":"Victorian Cancer Agency","doi-asserted-by":"crossref","award":["CRF10-20"],"award-info":[{"award-number":["CRF10-20"]}],"id":[{"id":"10.13039\/100008018","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008018","name":"Victorian Cancer Agency","doi-asserted-by":"crossref","award":["CRF16014"],"award-info":[{"award-number":["CRF16014"]}],"id":[{"id":"10.13039\/100008018","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008018","name":"Victorian Cancer Agency","doi-asserted-by":"crossref","award":["ECRF19003"],"award-info":[{"award-number":["ECRF19003"]}],"id":[{"id":"10.13039\/100008018","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Herman Trust University of Melbourne"},{"DOI":"10.13039\/501100015896","name":"Cancer Therapeutics Cooperative Research Centre","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100015896","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Australian Commonwealth Government and the University of Melbourne"},{"DOI":"10.13039\/501100022011","name":"Cancer Research UK Cambridge Institute, University of Cambridge","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100022011","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Cambridge Poynton Scholarship"},{"DOI":"10.13039\/501100003343","name":"Cambridge Trust","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003343","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100014589","name":"Chief Scientist Office, Scottish Government Health and Social Care Directorate","doi-asserted-by":"crossref","award":["SGP\/1"],"award-info":[{"award-number":["SGP\/1"]}],"id":[{"id":"10.13039\/100014589","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Medical Research Council","award":["MR\/N005813\/1"],"award-info":[{"award-number":["MR\/N005813\/1"]}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"crossref","award":["A15973"],"award-info":[{"award-number":["A15973"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"crossref","award":["A17263"],"award-info":[{"award-number":["A17263"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"crossref","award":["103721\/Z\/14\/Z"],"award-info":[{"award-number":["103721\/Z\/14\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009232","name":"Beatson Cancer Charity","doi-asserted-by":"crossref","award":["15-16-051"],"award-info":[{"award-number":["15-16-051"]}],"id":[{"id":"10.13039\/100009232","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100013342","name":"NIHR Imperial Biomedical Research Centre","doi-asserted-by":"crossref","award":["PSC593"],"award-info":[{"award-number":["PSC593"]}],"id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100013342","name":"NIHR Imperial Biomedical Research Centre","doi-asserted-by":"crossref","award":["P77646"],"award-info":[{"award-number":["P77646"]}],"id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000299","name":"Ovarian Cancer Action","doi-asserted-by":"crossref","award":["P76567"],"award-info":[{"award-number":["P76567"]}],"id":[{"id":"10.13039\/501100000299","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Ovarian carcinosarcoma (OCS) is an aggressive and rare tumor type with limited treatment options. OCS is hypothesized to develop via the combination theory, with a single progenitor resulting in carcinomatous and sarcomatous components, or alternatively via the conversion theory, with the sarcomatous component developing from the carcinomatous component through epithelial-to-mesenchymal transition (EMT). In this study, we analyzed DNA variants from isolated carcinoma and sarcoma components to show that OCS from 18 women is monoclonal. RNA sequencing indicated that the carcinoma components were more mesenchymal when compared with pure epithelial ovarian carcinomas, supporting the conversion theory and suggesting that EMT is important in the formation of these tumors. Preclinical OCS models were used to test the efficacy of microtubule-targeting drugs, including eribulin, which has previously been shown to reverse EMT characteristics in breast cancers and induce differentiation in sarcomas. Vinorelbine and eribulin more effectively inhibited OCS growth than standard-of-care platinum-based chemotherapy, and treatment with eribulin reduced mesenchymal characteristics and N-MYC expression in OCS patient-derived xenografts. Eribulin treatment resulted in an accumulation of intracellular cholesterol in OCS cells, which triggered a downregulation of the mevalonate pathway and prevented further cholesterol biosynthesis. Finally, eribulin increased expression of genes related to immune activation and increased the intratumoral accumulation of CD8+ T cells, supporting exploration of immunotherapy combinations in the clinic. Together, these data indicate that EMT plays a key role in OCS tumorigenesis and support the conversion theory for OCS histogenesis. Targeting EMT using eribulin could help improve OCS patient outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Genomic analyses and preclinical models of ovarian carcinosarcoma support the conversion theory for disease development and indicate that microtubule inhibitors could be used to suppress EMT and stimulate antitumor immunity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/0008-5472.can-21-4012","type":"journal-article","created":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T13:43:20Z","timestamp":1665150200000},"page":"4457-4473","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin"],"prefix":"10.1158","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1195-2296","authenticated-orcid":false,"given":"Gwo Yaw","family":"Ho","sequence":"first","affiliation":[{"name":"1The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia."},{"name":"2Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia."},{"name":"3The Royal Women's Hospital, Parkville, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9762-6127","authenticated-orcid":false,"given":"Elizabeth L.","family":"Kyran","sequence":"additional","affiliation":[{"name":"1The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia."},{"name":"2Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia."},{"name":"4Cancer Research UK Cambridge Institute, Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5704-0212","authenticated-orcid":false,"given":"Justin","family":"Bedo","sequence":"additional","affiliation":[{"name":"1The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia."},{"name":"5School of Computing and Information Systems, the University of Melbourne, Parkville, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6624-4698","authenticated-orcid":false,"given":"Matthew J.","family":"Wakefield","sequence":"additional","affiliation":[{"name":"1The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia."},{"name":"6Department of Obstetrics and Gynaecology, University of Melbourne, Parkville, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5260-3506","authenticated-orcid":false,"given":"Darren P.","family":"Ennis","sequence":"additional","affiliation":[{"name":"7Division of Cancer and Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, United Kingdom."},{"name":"8Institute of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6460-5290","authenticated-orcid":false,"given":"Hasan B.","family":"Mirza","sequence":"additional","affiliation":[{"name":"7Division of Cancer and Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8891-8873","authenticated-orcid":false,"given":"Cassandra J.","family":"Vandenberg","sequence":"additional","affiliation":[{"name":"1The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia."},{"name":"2Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3320-1565","authenticated-orcid":false,"given":"Elizabeth","family":"Lieschke","sequence":"additional","affiliation":[{"name":"1The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia."},{"name":"2Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5312-7994","authenticated-orcid":false,"given":"Andrew","family":"Farrell","sequence":"additional","affiliation":[{"name":"1The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4668-9408","authenticated-orcid":false,"given":"Anthony","family":"Hadla","sequence":"additional","affiliation":[{"name":"1The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia."},{"name":"2Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8773-3527","authenticated-orcid":false,"given":"Ratana","family":"Lim","sequence":"additional","affiliation":[{"name":"1The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6205-7342","authenticated-orcid":false,"given":"Genevieve","family":"Dall","sequence":"additional","affiliation":[{"name":"1The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia."},{"name":"2Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7166-2798","authenticated-orcid":false,"given":"James E.","family":"Vince","sequence":"additional","affiliation":[{"name":"1The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia."},{"name":"2Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2785-2767","authenticated-orcid":false,"given":"Ngee Kiat","family":"Chua","sequence":"additional","affiliation":[{"name":"1The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0022-5149","authenticated-orcid":false,"given":"Olga","family":"Kondrashova","sequence":"additional","affiliation":[{"name":"1The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2666-0934","authenticated-orcid":false,"given":"Rosanna","family":"Upstill-Goddard","sequence":"additional","affiliation":[{"name":"8Institute of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3641-9252","authenticated-orcid":false,"given":"Ulla-Maja","family":"Bailey","sequence":"additional","affiliation":[{"name":"8Institute of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2511-1965","authenticated-orcid":false,"given":"Suzanne","family":"Dowson","sequence":"additional","affiliation":[{"name":"8Institute of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9869-591X","authenticated-orcid":false,"given":"Patricia","family":"Roxburgh","sequence":"additional","affiliation":[{"name":"8Institute of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, United Kingdom."},{"name":"9Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5000-1680","authenticated-orcid":false,"given":"Rosalind M.","family":"Glasspool","sequence":"additional","affiliation":[{"name":"8Institute of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, United Kingdom."},{"name":"9Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2734-309X","authenticated-orcid":false,"given":"Gareth","family":"Bryson","sequence":"additional","affiliation":[{"name":"10Department of Pathology, Queen Elizabeth University Hospital, Glasgow, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0362-5597","authenticated-orcid":false,"given":"Andrew V.","family":"Biankin","sequence":"additional","affiliation":[{"name":"8Institute of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Scottish Genomes Partnership","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0955-0346","authenticated-orcid":false,"given":"Susanna L.","family":"Cooke","sequence":"additional","affiliation":[{"name":"8Institute of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6002-4619","authenticated-orcid":false,"given":"Gayanie","family":"Ratnayake","sequence":"additional","affiliation":[{"name":"3The Royal Women's Hospital, Parkville, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7340-9489","authenticated-orcid":false,"given":"Orla","family":"McNally","sequence":"additional","affiliation":[{"name":"3The Royal Women's Hospital, Parkville, Victoria, Australia."},{"name":"6Department of Obstetrics and Gynaecology, University of Melbourne, Parkville, Victoria, Australia."},{"name":"11Sir Peter MacCallum Cancer Centre Department of Oncology, University of Melbourne, Parkville, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7459-8576","authenticated-orcid":false,"given":"Nadia","family":"Traficante","sequence":"additional","affiliation":[{"name":"11Sir Peter MacCallum Cancer Centre Department of Oncology, University of Melbourne, Parkville, Victoria, Australia."},{"name":"12Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Australian Ovarian Cancer Study12,13","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0057-4744","authenticated-orcid":false,"given":"Anna","family":"DeFazio","sequence":"additional","affiliation":[{"name":"13Centre for Cancer Research, The Westmead Institute for Medical Research, Sydney, Australia."},{"name":"14The Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, Sydney, Australia."},{"name":"15Department of Gynaecological Oncology, Westmead Hospital, Sydney, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7130-7259","authenticated-orcid":false,"given":"S. John","family":"Weroha","sequence":"additional","affiliation":[{"name":"16Department of Oncology, Mayo Clinic, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9089-7525","authenticated-orcid":false,"given":"David D.","family":"Bowtell","sequence":"additional","affiliation":[{"name":"11Sir Peter MacCallum Cancer Centre Department of Oncology, University of Melbourne, Parkville, Victoria, Australia."},{"name":"12Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9387-7586","authenticated-orcid":false,"given":"Iain A.","family":"McNeish","sequence":"additional","affiliation":[{"name":"7Division of Cancer and Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, United Kingdom."},{"name":"8Institute of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, United Kingdom."},{"name":"9Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1102-8506","authenticated-orcid":false,"given":"Anthony T.","family":"Papenfuss","sequence":"additional","affiliation":[{"name":"1The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia."},{"name":"2Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia."},{"name":"12Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3689-5956","authenticated-orcid":false,"given":"Clare L.","family":"Scott","sequence":"additional","affiliation":[{"name":"1The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia."},{"name":"2Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia."},{"name":"3The Royal Women's Hospital, Parkville, Victoria, Australia."},{"name":"6Department of Obstetrics and Gynaecology, University of Melbourne, Parkville, Victoria, Australia."},{"name":"11Sir Peter MacCallum Cancer Centre Department of Oncology, University of Melbourne, Parkville, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9350-5520","authenticated-orcid":false,"given":"Holly E.","family":"Barker","sequence":"additional","affiliation":[{"name":"1The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia."},{"name":"2Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2022,10,7]]},"reference":[{"key":"2025112417324971100_bib1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ygyno.2016.04.025","article-title":"Patterns of care, predictors and outcomes of chemotherapy for ovarian carcinosarcoma: a national cancer database analysis","volume":"142","author":"Rauh-Hain","year":"2016","journal-title":"Gynecol Oncol"},{"key":"2025112417324971100_bib2","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1525-1438.2006.00760.x","article-title":"Current management of ovarian carcinosarcoma","volume":"17","author":"Mano","year":"2007","journal-title":"Int J Gynecol Cancer"},{"key":"2025112417324971100_bib3","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ygyno.2016.06.003","article-title":"Carcinosarcoma of the ovary, fallopian tube, and peritoneum: prognostic factors and treatment modalities","volume":"142","author":"Rauh-Hain","year":"2016","journal-title":"Gynecol Oncol"},{"key":"2025112417324971100_bib4","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/(SICI)1096-9896(199712)183:4<424::AID-PATH949>3.0.CO;2-L","article-title":"Molecular genetic evidence for the conversion hypothesis of the origin of malignant mixed mullerian tumours","volume":"183","author":"Abeln","year":"1997","journal-title":"J Pathol"},{"key":"2025112417324971100_bib5","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ygyno.2010.11.039","article-title":"Tissue-specific signatures of activating PIK3CA and RAS mutations in carcinosarcomas of gynecologic origin","volume":"121","author":"Growdon","year":"2011","journal-title":"Gynecol Oncol"},{"key":"2025112417324971100_bib6","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/01.pgp.0000092134.88121.56","article-title":"Carcinosarcomas (malignant mullerian mixed tumors) of the uterus and ovary: a genetic study with special reference to histogenesis","volume":"22","author":"Jin","year":"2003","journal-title":"Int J Gynecol Pathol"},{"key":"2025112417324971100_bib7","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0046-8177(98)90394-X","article-title":"Carcinosarcomas (malignant mixed mullerian tumors) of the female genital tract: comparative molecular analysis of epithelial and mesenchymal components","volume":"29","author":"Kounelis","year":"1998","journal-title":"Hum Pathol"},{"key":"2025112417324971100_bib8","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1038\/s41467-019-12985-x","article-title":"Clinically relevant molecular subtypes and genomic alteration-independent differentiation in gynecologic carcinosarcoma","volume":"10","author":"Gotoh","year":"2019","journal-title":"Nat Commun"},{"key":"2025112417324971100_bib9","doi-asserted-by":"crossref","first-page":"12238","DOI":"10.1073\/pnas.1614120113","article-title":"Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition","volume":"113","author":"Zhao","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025112417324971100_bib10","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ygyno.2011.12.418","article-title":"Carcinosarcoma of the ovary: a review of the literature","volume":"125","author":"del Carmen","year":"2012","journal-title":"Gynecol Oncol"},{"key":"2025112417324971100_bib11","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.semcancer.2019.10.006","article-title":"Genomics of gynaecological carcinosarcomas and future treatment options","volume":"61","author":"Barker","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"2025112417324971100_bib12","first-page":"114","article-title":"Frequent genetic heterogeneity in the clonal evolution of gynecological carcinosarcoma and its influence on phenotypic diversity","volume":"60","author":"Fujii","year":"2000","journal-title":"Cancer Res"},{"key":"2025112417324971100_bib13","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.1038\/ncomms6006","article-title":"Genomic analyses of gynaecologic carcinosarcomas reveal frequent mutations in chromatin remodelling genes","volume":"5","author":"Jones","year":"2014","journal-title":"Nat Commun"},{"key":"2025112417324971100_bib14","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1158\/0008-5472.CAN-12-3848","article-title":"HMGA2 is a driver of tumor metastasis","volume":"73","author":"Morishita","year":"2013","journal-title":"Cancer Res"},{"key":"2025112417324971100_bib15","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/(SICI)1098-2264(199908)25:4<316::AID-GCC2>3.0.CO;2-0","article-title":"HMGIC expression in human adult and fetal tissues and in uterine leiomyomata","volume":"25","author":"Gattas","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"2025112417324971100_bib16","first-page":"775","article-title":"HMGI-C expression patterns in human tissues. Implications for the genesis of frequent mesenchymal tumors","volume":"149","author":"Rogalla","year":"1996","journal-title":"Am J Pathol"},{"key":"2025112417324971100_bib17","doi-asserted-by":"crossref","first-page":"11689","DOI":"10.1038\/srep11689","article-title":"Low-molecular-mass secretome profiling identifies HMGA2 and MIF as prognostic biomarkers for oral cavity squamous cell carcinoma","volume":"5","author":"Chang","year":"2015","journal-title":"Sci Rep"},{"key":"2025112417324971100_bib18","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2559.2011.04121.x","article-title":"HMGA1 and HMGA2 protein expression correlates with advanced tumour grade and lymph node metastasis in pancreatic adenocarcinoma","volume":"60","author":"Piscuoglio","year":"2012","journal-title":"Histopathology"},{"key":"2025112417324971100_bib19","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1038\/modpathol.2015.96","article-title":"Prognostic value of HMGA2, CDK4, and JUN amplification in well-differentiated and dedifferentiated liposarcomas","volume":"28","author":"Saada-Bouzid","year":"2015","journal-title":"Mod Pathol"},{"key":"2025112417324971100_bib20","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1038\/onc.2013.328","article-title":"RKIP and HMGA2 regulate breast tumor survival and metastasis through lysyl oxidase and syndecan-2","volume":"33","author":"Sun","year":"2014","journal-title":"Oncogene"},{"key":"2025112417324971100_bib21","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1158\/1078-0432.CCR-10-2542","article-title":"Overexpression of HMGA2 promotes metastasis and impacts survival of colorectal cancers","volume":"17","author":"Wang","year":"2011","journal-title":"Clin Cancer Res"},{"key":"2025112417324971100_bib22","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.4161\/cc.6.21.4845","article-title":"Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2","volume":"6","author":"Park","year":"2007","journal-title":"Cell Cycle"},{"key":"2025112417324971100_bib23","doi-asserted-by":"crossref","first-page":"e18064","DOI":"10.1371\/journal.pone.0018064","article-title":"Deregulation of MYCN, LIN28B, and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancers","volume":"6","author":"Helland","year":"2011","journal-title":"PLoS ONE"},{"key":"2025112417324971100_bib24","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12943-015-0402-5","article-title":"Aberrant regulation of the LIN28A\/LIN28B and let-7 loop in human malignant tumors and its effects on the hallmarks of cancer","volume":"14","author":"Wang","year":"2015","journal-title":"Mol Cancer"},{"key":"2025112417324971100_bib25","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1158\/1078-0432.CCR-08-0196","article-title":"Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome","volume":"14","author":"Tothill","year":"2008","journal-title":"Clin Cancer Res"},{"key":"2025112417324971100_bib26","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/modpathol.2010.49","article-title":"HMGA2: a biomarker significantly overexpressed in high-grade ovarian serous carcinoma","volume":"23","author":"Mahajan","year":"2010","journal-title":"Mod Pathol"},{"key":"2025112417324971100_bib27","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1111\/cas.12488","article-title":"Eribulin mesylate reduces tumor microenvironment abnormality by vascular remodeling in preclinical human breast cancer models","volume":"105","author":"Funahashi","year":"2014","journal-title":"Cancer Sci"},{"key":"2025112417324971100_bib28","doi-asserted-by":"crossref","first-page":"e0170634","DOI":"10.1371\/journal.pone.0170634","article-title":"Use of Tumor-infiltrating lymphocytes (TILs) to predict the treatment response to eribulin chemotherapy in breast cancer","volume":"12","author":"Kashiwagi","year":"2017","journal-title":"PLoS ONE"},{"key":"2025112417324971100_bib29","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1038\/bjc.2014.80","article-title":"Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial\u2013mesenchymal transition (EMT) to mesenchymal\u2013epithelial transition (MET) states","volume":"110","author":"Yoshida","year":"2014","journal-title":"Br J Cancer"},{"key":"2025112417324971100_bib30","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0140-6736(11)60070-6","article-title":"Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study","volume":"377","author":"Cortes","year":"2011","journal-title":"Lancet"},{"key":"2025112417324971100_bib31","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1093\/annonc\/mdx284","article-title":"A randomized, open-label, multicenter, phase 3 study to compare the efficacy and safety of eribulin to treatment of physician's choice in patients with advanced non\u2013small cell lung cancer","volume":"28","author":"Katakami","year":"2017","journal-title":"Ann Oncol"},{"key":"2025112417324971100_bib32","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1200\/JCO.2013.52.4892","article-title":"Phase III open-label randomized study of eribulin mesylate versus capecitabine in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline and a taxane","volume":"33","author":"Kaufman","year":"2015","journal-title":"J Clin Oncol"},{"key":"2025112417324971100_bib33","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/S0140-6736(15)01283-0","article-title":"Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial","volume":"387","author":"Schoffski","year":"2016","journal-title":"Lancet"},{"key":"2025112417324971100_bib34","doi-asserted-by":"crossref","first-page":"18","DOI":"10.21105\/joss.00018","article-title":"Xenomapper: mapping reads in a mixed species context","author":"Wakefield","year":"2016","journal-title":"J Open Source Software"},{"key":"2025112417324971100_bib35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13059-019-1674-7","article-title":"Topconfects: a package for confident effect sizes in differential expression analysis provides a more biologically useful ranked gene list","volume":"20","author":"Harrison","year":"2019","journal-title":"Genome Biol"},{"key":"2025112417324971100_bib36","doi-asserted-by":"crossref","first-page":"111","DOI":"10.21105\/joss.00111","article-title":"Survival volume: interactive volume threshold survival graphs","volume":"1","author":"Wakefield","year":"2016","journal-title":"J Open Source Software"},{"key":"2025112417324971100_bib37","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1158\/0008-5472.CAN-10-2868","article-title":"LOXL2-mediated matrix remodeling in metastasis and mammary gland involution","volume":"71","author":"Barker","year":"2011","journal-title":"Cancer Res"},{"key":"2025112417324971100_bib38","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/00000478-199506000-00007","article-title":"Carcinosarcomas of the female genital tract. A pathologic study of 29 metastatic tumors: further evidence for the dominant role of the epithelial component and the conversion theory of histogenesis","volume":"19","author":"Sreenan","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"2025112417324971100_bib39","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/gcc.20947","article-title":"Expression profiles of carcinosarcoma of the uterine corpus-are these similar to carcinoma or sarcoma?","volume":"51","author":"Chiyoda","year":"2012","journal-title":"Genes Chromosomes Cancer"},{"key":"2025112417324971100_bib40","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.molonc.2014.01.008","article-title":"Molecular correlates of platinum response in human high-grade serous ovarian cancer patient-derived xenografts","volume":"8","author":"Topp","year":"2014","journal-title":"Mol Oncol"},{"key":"2025112417324971100_bib41","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1158\/1535-7163.MCT-15-0998","article-title":"CHK1 inhibition radiosensitizes head and neck cancers to paclitaxel-based chemoradiotherapy","volume":"15","author":"Barker","year":"2016","journal-title":"Mol Cancer Ther"},{"key":"2025112417324971100_bib42","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12885-018-4082-6","article-title":"Comparison of first-line chemotherapy regimens for ovarian carcinosarcoma: a single institution case series and review of the literature","volume":"18","author":"Brackmann","year":"2018","journal-title":"BMC Cancer"},{"key":"2025112417324971100_bib43","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fgene.2017.00031","article-title":"The LIN28\/let-7 pathway in cancer","volume":"8","author":"Balzeau","year":"2017","journal-title":"Front Genet"},{"key":"2025112417324971100_bib44","doi-asserted-by":"crossref","first-page":"e0126867","DOI":"10.1371\/journal.pone.0126867","article-title":"Conventional chemotherapy and oncogenic pathway targeting in ovarian carcinosarcoma using a patient-derived tumorgraft","volume":"10","author":"Glaser","year":"2015","journal-title":"PLoS ONE"},{"key":"2025112417324971100_bib45","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1158\/1541-7786.MCR-19-1203","article-title":"Destruction of a microtubule-bound MYC reservoir during mitosis contributes to vincristine's anticancer activity","volume":"18","author":"Becker","year":"2020","journal-title":"Mol Cancer Res"},{"key":"2025112417324971100_bib46","doi-asserted-by":"crossref","first-page":"5188","DOI":"10.1128\/MCB.15.9.5188","article-title":"The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro","volume":"15","author":"Alexandrova","year":"1995","journal-title":"Mol Cell Biol"},{"key":"2025112417324971100_bib47","doi-asserted-by":"crossref","first-page":"103375","DOI":"10.1016\/j.critrevonc.2021.103375","article-title":"Comparative effectiveness and safety of eribulin in advanced or metastatic breast cancer: a systematic review and meta-analysis","volume":"163","author":"Tanni","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"key":"2025112417324971100_bib48","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.celrep.2016.09.021","article-title":"Transcriptional profiling reveals a common metabolic program in high-risk human neuroblastoma and mouse neuroblastoma sphere-forming cells","volume":"17","author":"Liu","year":"2016","journal-title":"Cell Rep"},{"key":"2025112417324971100_bib49","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1158\/0008-5472.CAN-15-1970","article-title":"Candidate antimetastasis drugs suppress the metastatic capacity of breast cancer cells by reducing membrane fluidity","volume":"76","author":"Zhao","year":"2016","journal-title":"Cancer Res"},{"key":"2025112417324971100_bib50","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1172\/JCI0216452","article-title":"Consequences of cellular cholesterol accumulation: basic concepts and physiological implications","volume":"110","author":"Tabas","year":"2002","journal-title":"J Clin Invest"},{"key":"2025112417324971100_bib51","doi-asserted-by":"crossref","first-page":"728325","DOI":"10.3389\/fcell.2021.728325","article-title":"Mechanistic insights delineating the role of cholesterol in epithelial\u2013mesenchymal transition and drug resistance in cancer","volume":"9","author":"Abdulla","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2025112417324971100_bib52","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s42255-020-0174-0","article-title":"Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities","volume":"2","author":"Huang","year":"2020","journal-title":"Nat Metab"},{"key":"2025112417324971100_bib53","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.2147\/OTT.S136194","article-title":"Toll-like receptors 7 and 8 expression correlates with the expression of immune biomarkers and positively predicts the clinical outcome of patients with melanoma","volume":"10","author":"Zhang","year":"2017","journal-title":"Onco Targets Ther"},{"key":"2025112417324971100_bib54","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13058-021-01418-7","article-title":"High IRF8 expression correlates with CD8 T-cell infiltration and is a predictive biomarker of therapy response in ER-negative breast cancer","volume":"23","author":"Gatti","year":"2021","journal-title":"Breast Cancer Res"},{"key":"2025112417324971100_bib55","doi-asserted-by":"crossref","first-page":"625207","DOI":"10.3389\/fonc.2021.625207","article-title":"MYCN drives a tumor immunosuppressive environment which impacts survival in neuroblastoma","volume":"11","author":"Raieli","year":"2021","journal-title":"Front Oncol"},{"key":"2025112417324971100_bib56","first-page":"2929","article-title":"Eribulin promotes antitumor immune responses in patients with locally advanced or metastatic breast cancer","volume":"38","author":"Goto","year":"2018","journal-title":"Anticancer Res"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/doi\/10.1158\/0008-5472.CAN-21-4012\/3213122\/can-21-4012.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/82\/23\/4457\/3364333\/4457.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/82\/23\/4457\/3364333\/4457.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T22:33:13Z","timestamp":1764023593000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/82\/23\/4457\/710688\/Epithelial-to-Mesenchymal-Transition-Supports"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,7]]},"references-count":56,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2022,10,7]]},"published-print":{"date-parts":[[2022,12,2]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-21-4012","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.30699401","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.24135187","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.24135187.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.24135184.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.24135184","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30699404","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6514283","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22432967","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22432967.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6514283.v2","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22432970.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22432970","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6514283.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,7]]}}}